Back to mobile site

More on DYAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.8 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DYAX Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 116.69M
Short-term investments 191.7M
Accounts receivable, net of allowances for doubtful accounts of $45 at June 30, 2011 and December 31, 2010, respectively 13.18M
Inventory 4.77M
Current portion of restricted cash
Other current assets 6.32M
Total current assets 332.66M
Fixed assets, net 5.21M
Restricted cash 1.1M
Other assets 9.95M
Total assets 348.92M
Accounts payable and accrued expenses 24.8M
Current portion of deferred revenue 3.74M
Current portion of long-term obligations
Other current liabilities 0
Total current liabilities 28.54M
Deferred revenue 3.12M
Note payable 0
Long-term obligations
Deferred rent and other long-term liabilities
Total liabilities 34.45M
Commitments and contingencies (Notes 7 and 9) 0
Preferred stock, $0.01 par value; 1,000,000 shares authorized; 0 shares issued and outstanding 0
Common stock, $0.01 par value; 200,000,000 shares authorized; 98,748,086 and 98,508,487 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 1.47M
Additional paid-in capital
Accumulated deficit -573.22M
Accumulated other comprehensive income 82K
Total stockholders' equity (deficit) 314.47M
Total liabilities and stockholders' equity (deficit) 348.92M